Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT GolfBT MindrushBT Best Banks
Search

COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
News
markets
stocks
ERIS Lifesciences Ltd
ERIS Lifesciences Ltd

ERIS Lifesciences Ltd (ERIS) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 4,33,232
Apr 24, 2025 Closed
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹1,512.00
₹37.80 (2.56%)
1,426.80Low
Today’s Performance
1,521.80High
815.85Low
52 Week’s Performance
1,593.90High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day2.56%
  • 1 Week9.33%
  • 1 Month11.17%
  • 3 Months25.73%
  • 6 Months17.78%
  • 1 Year73.77%
  • 3 Years29.82%
  • 5 Years25.57%

bt_logoPeer Comparison

ERIS Lifesciences Ltd
Sun Pharmaceutical Industries Ltd
Divis Laboratories Ltd
Cipla Ltd
Price

₹1,512.00

ERIS Lifesciences Ltd

₹1,803.90

Sun Pharmaceutical Industries Ltd

₹6,215.50

Divis Laboratories Ltd

₹1,551.70

Cipla Ltd

bt_logoStock Summary

  • Face Value (₹)1.00
  • Beta0.56
  • 52-Week Low (₹)815.85
  • 52-Week High (₹)1,593.90
  • Price-to-Book (X)*7.43
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*62.48
  • Earnings Per Share (₹)24.19
  • Market Cap (₹ Cr.)*20,587.78
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Gold or Silver?| Jim Rogers: I’ll Buy More Gold If Prices Dip – Here’s Why0:43Gold or Silver? | Jim Rogers: I’ll Buy More Gold If Prices Dip – Here’s Why
After Pahalgam Bloodshed, India Strikes Back: Indus Treaty Halted, Borders Shut, Justice Promised3:59After Pahalgam Bloodshed, India Strikes Back: Indus Treaty Halted, Borders Shut, Justice Promised
PM Modi From Bihar Stage: “India Will Punish Pahalgam Attackers Beyond Their Imagination4:32PM Modi From Bihar Stage: “India Will Punish Pahalgam Attackers Beyond Their Imagination"
Market Masters | Kenneth Andrade On Trump Tariff Impact, Market Outlook, Sectors, Mutual Funds & More24:48Market Masters | Kenneth Andrade On Trump Tariff Impact, Market Outlook, Sectors, Mutual Funds & More
Gold at Historic Highs: Jim Rogers Explains Why He’s Holding and Still Buying Bullion0:43Gold At Historic Highs: Jim Rogers Explains Why He’s Holding And Still Buying Bullion
On Ground In Pahalgam: Terror Attack Empties The Valley’s Most Loved Tourist Town In Just Hours2:47On Ground In Pahalgam: Terror Attack Empties The Valley’s Most Loved Tourist Town In Just Hours
Akshay Bhagwat On Nestle’s Momentum V/S HUL’s Stagnation1:01Akshay Bhagwat On Nestle’s Momentum V/S HUL’s Stagnation
India Suspends Indus Water Treaty: Dry Days Ahead For Pakistan & Its Economy?4:10India Suspends Indus Water Treaty: Dry Days Ahead For Pakistan & Its Economy?
Central Banks Trigger Gold Surge – What It Means For You1:02Central Banks Trigger Gold Surge – What It Means For You
Strong Sectors Vs Stock Picking – What Works Now?1:38Strong Sectors Vs Stock Picking – What Works Now?
View more

bt_logoFinancial Analysis

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

bt_logoRatio Analysis

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

bt_logoShare Holding Pattern

Summary (As on 31 Mar 2025)
Promoters (54.85%)
Domestic institutional investors (18.07%)
Foreign Institutional Investors (17.39%)
Public & Others (9.31%)
Government Holding (0.00%)
Corporate Holding (0.38%)

bt_logoDeals

06 Jul, 2023BUY
HDFC MUTUAL FUND
Qty675000
Average Price₹697
06 Jul, 2023BUY
HDFC MUTUAL FUND
Qty1350000
Average Price₹697
06 Jul, 2023SELL
SHAH RAKESH
Qty2700000
Average Price₹697
30 Jun, 2023SELL
SHAH RAKESH
Qty2800000
Average Price₹680
30 Jun, 2023BUY
BAKSHI AMIT INDUBHUSAN
Qty2800000
Average Price₹680
25 Nov, 2019BUY
EMERALD INVESTMENTS LIMITED
Qty700002
Average Price₹411.5
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.

bt_logoFAQ's

What was ERIS Lifesciences Ltd share price previously?
ERIS Lifesciences Ltd share price was up by 2.56% from the previous closing price of ₹1,474.20.
Who are peers of ERIS Lifesciences Ltd?
The peers of ERIS Lifesciences Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd.
Who is/are the promoter/promoters of ERIS Lifesciences Ltd?
The promotor/promotors of ERIS Lifesciences Ltd are Amit Indubhushan Bakshi, Kaushal Kamlesh Shah, Inderjeet Singh Negi, Krishnakumar Vaidyanathan, Sujesh Vasudevan, Prashant Gupta, Rajeev Narotam Dalal, Kalpana Unadkat, Milind Talegaonkar.
What has been 52-week high of ERIS Lifesciences Ltd stocks?
The highest price of ERIS Lifesciences Ltd stock is ₹1,593.90 in the last 52-week.
What is the share price of ERIS Lifesciences Ltd (ERIS) today on NSE?
As on Apr 24, 2025 ERIS Lifesciences Ltd (ERIS)’s share price on NSE is Rs 1512
What is the market cap of ERIS Lifesciences Ltd (ERIS)?
The current market capitalisation of ERIS Lifesciences Ltd (ERIS) is 20,587.78 crores
What is ERIS Lifesciences Ltd Share symbol?
The symbol of ERIS Lifesciences Ltd is ERIS.
What is the PE ratio of ERIS Lifesciences Ltd (ERIS)?
The current PE ratio of ERIS Lifesciences Ltd (ERIS) is 62.48.
What is the PB ratio of ERIS Lifesciences Ltd (ERIS)?
The current PB ratio of ERIS Lifesciences Ltd (ERIS) is 7.43.
Today’s High & Low share prices of ERIS Lifesciences Ltd (ERIS) on NSE?
Today, the share price of ERIS Lifesciences Ltd (ERIS) on NSE touched a high of Rs 1521.8 and a low of Rs 1426.8
What price did ERIS Lifesciences Ltd (ERIS) shares open on the NSE today?
On NSE, the share price of ERIS Lifesciences Ltd (ERIS) opened at Rs 1490
What is the 52-week high of ERIS Lifesciences Ltd (ERIS)?
The 52-week high price of ERIS Lifesciences Ltd (ERIS) is Rs 1,593.90
What is the 52-week low of ERIS Lifesciences Ltd (ERIS)?
The 52-week low price of ERIS Lifesciences Ltd (ERIS) is Rs 815.85

bt_logoAbout ERIS Lifescience

ERIS Lifesciences Ltd, incorporated in the year 2007, has its registered office in 8th Floor Commerce House -IV, Prahladnagar 100 FT Road, Ahmedabad, Gujarat, 380015, 91-79-30451000, 91-79-48903474. The main industry in which ERIS Lifesciences Ltd operates is Pharmaceuticals - Indian - Formulations.

Auditor/Auditors for ERIS Lifesciences Ltd is/are Deloitte Haskins & Sells LLP. In the main management, Amit Indubhushan Bakshi is chairman and Milind Talegaonkar is the company secretary for ERIS Lifesciences Ltd.

  • AIB
    Amit Indubhushan BakshiChairman & Managing Director
  • KKS
    Kaushal Kamlesh ShahWhole-time Director
  • ISN
    Inderjeet Singh NegiWhole-time Director
  • KV
    Krishnakumar VaidyanathanWhole Time Director & COO
  • SV
    Sujesh VasudevanIndependent Non Exe. Director
  • PG
    Prashant GuptaIndependent Non Exe. Director
  • RND
    Rajeev Narotam DalalIndependent Non Exe. Director
  • KU
    Kalpana UnadkatIndependent Non Exe. Director
  • MT
    Milind TalegaonkarCompany Sec. & Compli. Officer

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.